Skip to main content
. 1998 Apr 14;95(8):4630–4634. doi: 10.1073/pnas.95.8.4630

Table 1.

Glycemic and hemodynamic measurements performed in diabetic animals and diabetic animals treated with ALT-711 for 1 or 3 weeks

Nondiabetic controls 9 weeks diabetes Diabetes + ALT-711 for:
1 week 3 weeks
Blood glucose (mmol/liter) 6.0 ± 2.0 24.5 ± 3.2* 23.3 ± 2.9 24.0 ± 3.5
HbA1c (%) 1.3 ± 0.3 4.7 ± 0.4* 4.6 ± 0.5 4.6 ± 0.5
Body weight (g) 354 ± 29 258 ± 14* 255 ± 16 251 ± 15
Systolic BP (mm Hg) 126 ± 11 111 ± 12* 108 ± 11 109 ± 13
Diastolic BP (mm Hg) 98 ± 8 87 ± 15 83 ± 10 85 ± 16
Mean BP (mm Hg) 111 ± 10 98 ± 15 95 ± 10 96 ± 16
Heart rate (beats/min) 412 ± 66 321 ± 32* 296 ± 25 320 ± 34
Cardiac output (ml/min) 69 ± 6 59 ± 15 62 ± 10 75 ± 18
Cardiac index (ml/min per cm2) 0.19 ± 0.02 0.19 ± 0.05 0.21 ± 0.03 0.25 ± 0.07
TPR (103.dyne.sec/cm5) 128 ± 17 141 ± 46 126 ± 31 107 ± 34
TPR index (dyne.sec/cm3) 359 ± 35 463 ± 170 429 ± 106 357 ± 123
SAC (10−3 ml/mm Hg) 6.9 ± 0.6 5.6 ± 1.8* 6.4 ± 1.6 7.3 ± 3.3
Zc (103.dyne.sec/m5) 8.7 ± 3.1 13.3 ± 4.6* 11.7 ± 4.2 8.6 ± 3.8

Values are mean ± SD. HbA1c, glycated hemoglobin; cardiac index, cardiac output corrected for body surface area; TPR index, TPR corrected for body surface area. 

*

P < 0.05 vs. nondiabetic control animals. 

P < 0.05;  

P = 0.075 by ANOVA vs. 9-week diabetic animals.